Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Am J Rhinol Allergy ; 37(3): 245-246, 2023 05.
Article in English | MEDLINE | ID: covidwho-20243606
Ear Nose Throat J ; 101(10_suppl): 12S-14S, 2022 Dec.
Article in English | MEDLINE | ID: covidwho-1910025


This case study demonstrates a 58-year-old female who contracted COVID-19 post-vaccination presenting with severe left-sided facial pain, headaches, and dyspnea. A computed tomography was ordered and showed acute sinusitis, and upon bedside endoscopy, the patient was shown to have necrosis of the left-sided middle turbinate with no discoloration, palate necrosis, or facial changes. All samples of the necrotic tissue were reported to be invasive fungal sinusitis. The entire turbinate was resected in the operating room and ethmoid, frontal, and maxillary sinuses were healthy. Chest x-rays post-operatively showed pulmonary effusions and edema although the patient was not stable enough for a lung examination to rule out a pulmonary fungal infection. A bedside endoscopy showed no further necrosis post-operatively although a repeat endoscopy showed duskiness at the lateral attachment of the basal lamella right at the most posterior resection of the middle turbinate. The patient was placed on multiple antifungal agents. The patient remained in hypoxemic respiratory failure and septic shock while on pressors and 2 weeks following this, expired. Post-COVID-19 patients have been shown in the literature to have an increased risk of developing invasive fungal sinusitis (IFS) and all IFS cases during active COVID-19 infection have had a 100% mortality rate.

COVID-19 , Invasive Fungal Infections , Sinusitis , Humans , Female , Middle Aged , COVID-19/complications , Sinusitis/complications , Sinusitis/diagnosis , Turbinates , Necrosis
Ann Otol Rhinol Laryngol ; 130(7): 810-817, 2021 Jul.
Article in English | MEDLINE | ID: covidwho-949219


OBJECTIVE: To compare the patient experience of a virtual otolaryngology clinic visit to an in-person visit, especially with its significantly increased implementation during the COVID-19 pandemic. METHODS: Patient satisfaction (PS) metrics from the Clinician and Group Consumer Assessment of Healthcare Providers and Systems survey were queried from March 1, 2020 to May 1, 2020 for telehealth visits and January 1, 2020 to March 1, 2020 for in-person visits. Overlapping and comparable questions were analyzed using Mann-Whitney U test, Chi-square test for independence, and Student's t-test. RESULTS: There were 1284 partial or complete PS surveys from in-person visits and 221 partial or complete virtual PS surveys. There were statistically significantly worse virtual visit evaluations of provider listening, conveyance of information, likelihood to recommend, and overall provider ratings compared to in-person visits. CONCLUSION: Telehealth has become the new norm for most healthcare providers in the United States. This study demonstrates some of the initial shortcomings of telehealth in an otolaryngology practice and identifies challenges with interpersonal communication that may need to be addressed as telehealth becomes increasingly prevalent. LEVEL OF EVIDENCE: 3.

COVID-19/epidemiology , Otolaryngology/organization & administration , Pandemics , Patient Satisfaction , Remote Consultation , Ambulatory Care , California/epidemiology , Communication , Health Care Surveys , Humans , Physician-Patient Relations , SARS-CoV-2